There Has to be a Better Way

Interview with Steve Zielinski, VP of Sales for Interrad Medical

Dr. Michael Rosenberg, an Interventional Radiologist at the University of Minnesota, had seen enough. Yet another catheter had pulled out accidentally from one of his patients. To solve this problem, Dr. Rosenberg would then have to re-insert the catheter and secure it in place with sutures. In order to alleviate this burden, he invented what is now the SecurAcath, a subcutaneous catheter securement system.  In this interview with Steve Zielinski, the VP of Sales for Interrad Medical, we learn more about this this unique medical device and the history of Interrad Medical.

Interview Highlights with Steve Zielinski

  • What’s so different about the SecurAcath medical device?

  • Has anyone actually said “no” when comparing the SecurAcath to alternative medical devices?

  • Why Interrad Medical may eventually employ the Intel business model.

  • Interrad Medical’s recent unique Series C round of financing with angel investors.

  • Steve’s advice for medical device sales reps pertaining to large medical device companies vs. small start-ups.

  • The importance of understanding the nuances of the specialist physicians you’re calling on.

Premium Members Only

Premium Members Only

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You May Like These Articles

Medsider Premium

Become a premium member and unlock access to exclusive Medsider benefits.

Medsider Mentors

Medsider Mentors

Medsider Playbooks

Medsider Playbooks

Playbook

A Guide to Widespread Adoption in Medtech

In medtech, developing novel, impactful technology is often just the starting line. The real race begins when you try to integrate your solution into the often-resistant healthcare system – a hurdle that has tripped up countless promising companies. Here are the key strategies and lessons from five veterans in the medtech space on how to overcome this hurdle.

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest